from the headway-for-head-drugs dept.
grammar fascist writes "The AP wire reports that Japanese medical researchers have developed a DNA-based vaccine that reduces the brain plaque beta amyloid without the severe brain inflammation that plagued successes in 2002. From the story 'The deposits have been cut by between 15.5 percent and 38.5 percent in mice, with no major side effects, researchers said Monday in the online edition of Proceedings of the National Academy of Sciences [...] If all goes well, this type of treatment might be available for people in six or seven years, [lead researcher Yoh Matsumoto] said.'"
Never ask two questions in a business letter. The reply will discuss
the one you are least interested, and say nothing about the other.